The insufficiency of retinal circulation in humans is associated with diseases of the eye and systemic disorders such as hypertension and diabetes mellitus. To maintain a constant blood supply in the retina, blood pressure in retinal functional arterioles is known to be regulated precisely [1] . The retinal arterioles are regulated by autonomic neural and humoral factors [2, 3] . In earlier studies, the reactivities of isolated calf retinal small arteries to vasoactive substances were investigated comprehensively by measuring isometric wall tension. Hoste et al. [4] demonstrated that phenylephrine, a selective ␣ 1 -adrenoceptor agonist, caused a contraction of the bovine retinal small arteries in a dose-dependent manner. 5-Hydroxytryptamine (5-HT), noradrenaline (NA) [5] , prostaglandin F 2␣ (PG F 2␣ ), and a thromboxane A 2 analog (TX A 2 ) [6] also increased the wall tension of the arteries. Furthermore, acetylcholine (ACh)-and PG I 2 -induced relaxations were examined in the precontracted bovine retinal small arteries [5, 6] . No report, however, exists to Japanese Journal of Physiology, 52, 285-291, 2002 Key words: cow, retinal arteriole, acetylcholine, nitric oxide, pressurized preparation.
dose-dependent vasodilatation in the pressurized retinal arterioles preconstricted with high-potassium solution (40 mM K ϩ ). The decreasing order of potency in the vasodilative responses was as follows: isocarbacyclinϾSNPϾACh. The ACh-induced vasodilatation was suppressed significantly by pretreatment with N -nitro-L-arginine methyl ester (L-NAME) (3ϫ10 Ϫ5 M). A treatment with L-arginine (10 Ϫ3 M) in the presence of 3ϫ 10 Ϫ5 M L-NAME reversed completely the L-NAME-induced reduction of the vasodilatation. These results suggest that ACh causes the production and release of endogenous nitric oxide or its related compounds, which results in vasodilatation of the pressurized bovine retinal functional arterioles. [Japanese Journal of Physiology, 52, [285] [286] [287] [288] [289] [290] [291] 2002] examine the potential effects of vasoactive substances on changes in the diameter of pressurized retinal functional arterioles.
Thus we have attempted to establish an experimental procedure for developing pressurized retinal resistance-sized arterioles and for examining changes in the diameter of pressurized arterioles isolated from bovine retina. Also, we focused on evaluating responses of the resistance-sized arterioles to vasoactive substances with special reference to nitric oxide (NO)-mediated vasodilatation.
MATERIALS AND METHODS
Preparation and dissection. The techniques for the dissection and cannulation of bovine retinal resistance-sized arterioles were adopted from the methods originally described by Duling et al. [7] . A total of 33 bovine eyes was used in this study. The eyes were dissected quickly after the cattle had been slaughtered. The anterior segment and the vitreous body were cut away, and the retina with the sclera was placed in a cooled (4°C) dissection chamber filled with 3-(N-morpholino) propanesulfonic acid (MOPS)-buffered physiological salt solution containing 1% dialyzed bovine serum albumin (BSA). The chamber was placed on a recessed Plexiglas well, and chilled fluid was circulated through the well jacket from an Eyela cooling thermopump (model CTP 100, Tokyo Rikakikai, Tokyo, Japan). Under a dissecting microscope, a segment of retinal resistance-sized arteriole, situated just after the first intraretinal branching ( Fig.  1 ) (97-185 m in the luminal diameter and ϳ3 mm in length), was carefully dissected free of accompanying veins and surrounding connective tissues. The isolated functional arteriole was carefully transferred from the dissection chamber to a temperature-controlled cannulation chamber (volume, 1 ml) mounted on the stage of an inverted microscope (model IMT-2, Olympus, Tokyo, Japan).
Cannulation. The isolated functional arteriole was cannulated at both ends by using a system of concentric glass pipettes (a perfusion pipette within a holding pipette, White Instruments, Bradbury Park, MD, USA) mounted on a Narishige micromanipulator MJ-1 (Narishige, Tokyo, Japan) that was equipped on the stage of the inverted microscope. With vacuum applied to the lumen of the holding pipette, one end of the arteriole was gently pulled into the pipette. The perfusion pipette was inserted into the lumen of the arteriole. When one end of the arteriole was thus cannulated, it was perfused at a hydrostatic pressure of 20 mmHg to remove red blood cells. Then the other end of the arteriole was cannulated in the same manner.
Instrumentation. After the cannulation, both micropipettes were connected to water manometers used to adjust intraluminal pressure via independent reservoirs (Fig. 2) . The image of the cannulated arteriole was recorded with a video camera (model C2400, Hamamatsu Photonics, Hamamatsu, Japan) and displayed on a television monitor. The arterial luminal diameters were measured manually with a video caliper incorporated with a MacLab Chart v3.2 (AD Instrument, Castle Hill, Australia) (Fig. 2) .
Experimental protocols. The retinal arteriole was set to its in situ length, and intraluminal pressure was set at 60 mmHg [8] . A constant pressure gradient (⌬P) of 5 mmHg between the upstream and downstream pipettes was established to maintain a steady flow through the lumen. The organ bath temperature was raised slowly (1°C/min) and kept at 37.0Ϯ0.5°C by the use of a Haake FE-2 and a bipolar temperature controller (model TC-202, Medical Systems, Tokyo, Japan). The solution in the organ bath was then changed to a MOPS solution without albumin and perfused extraluminally at a constant rate of flow (0.9 ml/min) with a Perista pump (model SJ-1211, Atto, Tokyo, Japan). The functional arterioles were equilibrated for at least 60 min; the contractile response to a high potassium MOPS solution (80 mM K ϩ ) was then obtained. The high potassium solution was administered extraluminally to the organ bath. The arterioles whose diameters were not shortened more than 20% by the high potassium solution were discarded for further studies.
Four sets of experiments were performed. In the first series, changes in the diameter of the pressurized arterioles at the ⌬P of 5 mmHg were measured before and after a cumulative application of U46,619 (10 Ϫ10 to 10 Ϫ5 M), NA (10 Ϫ10 to 10 Ϫ4 M), PG F 2␣ (10 Ϫ10 to 3ϫ 10 Ϫ4 M), and 5-HT (10 Ϫ10 to 10 Ϫ4 M). Dose-response curves for these agonists were then constructed. The agonists were administered extraluminally with stepwise increases by a factor of 10 to make up the doseresponse relationships. The retinal arteries were allowed to stabilize for 8 min at each concentration of the agonists.
In the second series, the effects of vasodilatative agents such as sodium nitroprusside (SNP) (10 Ϫ10 to 10 Ϫ4 M), ACh (10 Ϫ10 to 10 Ϫ4 M), isocarbacyclin (10
Ϫ10
to 10 Ϫ4 M), and isoproterenol (ISP) (10 Ϫ10 to 10
were examined in the pressurized retinal functional arterioles. Changes in the diameter of the arterioles at the ⌬P of 5 mmHg were measured before and after the cumulative application of these agents by the use of 10-fold concentration increments; Dose-response curves for the agents were then constructed. In this series, all preparations were preconstricted by an extraluminal application of high potassium MOPS solution (40 mM K ϩ ). The functional arterioles were allowed to stabilize for 8 min at each concentration of the agents.
In the third series, changes in the diameter of the arterioles at the ⌬P of 5 mmHg were measured before and after a cumulative application of ACh (10 Ϫ10 to 10 Ϫ4 M, using tenfold concentration increments). A dose-response curve for ACh was then constructed. In this series, all preparations were precontracted by the high concentration of potassium (40 mM). The arterioles were allowed to stabilize at each concentration of ACh for 8 min. After a 40-min recovery period, the cumulative application of ACh was repeated in the presence of 3ϫ10 Ϫ5 M N w -nitro-L-arginine methyl ester (L-NAME). The arteriolar preparation was treated with the inhibitor for 30 min before we constructed dose-response curves for ACh. In the control experiments, time-dependent responses to ACh were examined.
In the fourth series, dose-response curves for ACh were obtained before and during 30 min of the application of 3ϫ10 Ϫ5 M L-NAME and 10
to the organ bath. Drugs. The composition of the MOPS solution (in mM) was as follows: 145 NaCl, 4.7 KCl, 2.0 CaCl 2 , 1.17 MgSO 4 , 2.0 pyruvate, 5.0 glucose, 0.02 EDTA, and 2.0 MOPS. The pH was adjusted to 7.40Ϯ 0.02 at 37°C. Solutions used for dissection, cannulation, and perfusion contained 1% BSA. An isotonic high-potassium MOPS solution was prepared by substituting NaCl with an equimolar amount of KCl. ACh chloride, l-ISP hydrochloride, and isocarbacyclin were obtained from Daiichi Seiyaku (Tokyo, Japan), Nikken Kagaku (Tokyo, Japan), and Teijin (Tokyo, Japan), respectively. SNP was obtained from Merck (Darmstadt, Germany). PG F 2␣ was obtained from Ono Yakuhin (Osaka, Japan). MOPS, BSA, L-NAME hydrochloride, L-arginine hydrochloride, l-norepinephrine bitartrate, 5-HT creatinine sulfate, and U46,619 were obtained from Sigma Chemical (St. Louis, MO, USA). Isocarbacyclin was dissolved in ethanol and diluted with MOPS solution just before use. The concentration of the solvent was confirmed to produce no significant effect on high potassium MOPS solution-induced contraction of the arteriolar preparations. The other drugs were directly dissolved in the MOPS solution.
Statistics. Experimental data in the text, figures, and tables were expressed as meansϮSEM. The degrees of constriction and dilatation induced by the agonists were expressed as a percentage of the 80 mM K ϩ solution-induced contraction and 40 mM K ϩ solution-induced precontraction level in each pressurized arteriole, respectively. The comparisons of dose-response curves under different treatments were made by the use of one-way analysis of variance and tested with Fisher's protected least-significant differences multiple-range test. Differences in the mean diameters before and after the treatment of inhibitors were com-pared by paired or unpaired t-tests. A value of pϽ0.05 was considered significant.
RESULTS
Effects of vasoconstrictor agents on the diameters of pressurized retinal functional arterioles U46,619, NA, PG F 2␣ , and 5-HT produced dose-dependent constrictions in the diameters of the pressurized retinal functional arterioles. Representative photomicrographs that demonstrate 10 Ϫ4 M PG F 2␣ -mediated vasoconstriction are shown in Fig. 3A and B (Fig.  3A: control) . The dose-response curves for U46,619, NA, PG F2 ␣ , and 5-HT are summarized in Fig. 4 . The basal internal diameter, pD 2 , a negative logarithm of EC 50 , and E max values of the vasoconstrictor agents are shown in Table 1 . No significant differences were found in the basal internal diameters of the pressurized retinal functional arterioles. The decreasing order of potency (pD 2 value) in the vasoconstrictive responses was as follows: 5-HTϭU46,619ϾNAϾPG F 2␣ . On the other hand, the order of E max was PG F 2␣ ϭ U46,619ϾNAϾ5-HT. Each value is presented as meanϮSEM. n, number of preparations; E max , maximum diameter shortening expressed as a percentage of 80 mM K ϩ solution-induced diameter shortening (K ϩ constriction); pD 2 , Ϫlog[EC 50 ] in which EC 50 is the concentration of agonists causing 50% of each maximum response; Basal diameter, internal diameter of each arteriole immediately after the equilibration period; NA, noradrenaline; PG F 2␣ , prostaglandin F 2␣ ; 5-HT, 5-hydroxytryptamine.
ACh-induced vasodilatation. The cumulative concentration-vasodilative response curves for SNP, ACh, isocarbacyclin, and ISP are summarized in Fig. 5 . Table 2 shows the basal internal diameter, pD 2 , and E max values for the vasodilative-agent-induced responses. The actual pD 2 and E max values of ISP, however, could not be calculated because its concentration-response curve did not reach a plateau with the concentration range up to 10 Ϫ4 M. The decreasing order of potency in vasodilative responses was isocarbacyclinϾSNPϾACh; of E max it was SNPϾisocarba-cyclinϾACh.
Effects of L-NAME and/or L-arginine on the ACh-induced vasodilatation
The dose-vasodilative response curve for ACh was significantly suppressed by pretreatment with 3ϫ 10 Ϫ5 M L-NAME (Fig. 6) . The L-NAME-induced inhibition was completely reversed by an additional treatment with 10 Ϫ3 M L-arginine (nϭ6) (Fig. 6 ).
DISCUSSION
Many responses of the retinal vasculature to physiologic and pharmacologic stimuli in intact organs are difficult to interpret because of highly complex interactions among parenchymal cells, vascular smooth muscle cells, endothelial cells, and autonomic nerves. A variety of useful in vitro preparations including strips and rings [9] has been developed, but virtually all are limited in application to relatively large retinal arteries.
Regional and longitudinal differences in reactivity in the peripheral vasculature are well known [7] , but the major site of resistance in most organs resides in functional arterioles that are much smaller than the retinal arteries commonly studied by established in vitro methods [9] . Thus the extrapolation of conclusions from studies on larger arteries to the behavior of resistance-sized functional arterioles remains uncertain. So with Duling's technique [7] we have first attempted to establish the pressurized preparation that will be very useful in elucidating the physiology and Pressurized Retinal Arterioles Each value is presented as meanϮSEM. n, number of preparations; E max , maximum dilation expressed as a percentage of preconstriction induced by 40 mM K ϩ solution; pD 2 , Ϫlog[EC 50 ] in which EC 50 is the concentration of agonists causing 50% of each maximum response; Basal diameter, internal diameter of each artery immediately after the equilibration period; SNP, sodium nitroprusside; ACh, acetylcholine; ICC, isocarbacyclin, a stable PG I 2 analogue; ISP, isoproterenol. pharmacology of resistance-sized functional arterioles in the retinal terminal vasculature.
Retinal vessels have also an ability to maintain the constant intraluminal pressure of the small arteries and arterioles in spite of fluctuating systemic arterial blood pressure and changing intraocular pressure [1, 10] . This ability has been termed autoregulation. The myogenic tone of vascular smooth muscles in the small arteries and arterioles plays a pivotal role of the autoregulation in vivo. One of the essential studies in the clarification of autoregulatory capacity is to examine the pharmacological properties of the resistancesized functional arterioles in the retinal vasculature. Thus in our present study we used the pressurized retinal functional arterioles of 97-185 m in internal diameter, which can be recognized as resistance arterioles in the retinal circulation [11] . Moreover, the pressurized retinal functional arterioles used may play an important role in maintaining the autoregulatory capacity of the retinal circulation in vivo.
Changes in blood flow in the vasculature to regulate the vascular diameter are well known; they are dependent on the integrity of the endothelial function [12, 13] . Indeed, share-stress-induced endothelium-dependent NO and vasodilator prostaglandins have been shown in many studies [14] . In this study the isolated bovine retinal functional arterioles were cannulated at both ends with glass micropipettes, then pressurized at a constant pressure of 60 mmHg. The pressurized functional arterioles were then perfused intraluminally with MOPS-buffered solution. The microperfusion technique, compared with the strip preparation, easily enables the in vivo physiological condition of the functional arterioles to be mimicked, i.e., keeping the circumferential wall tension at physiological value in vitro and allowing no biological damage of endothelial cells, smooth muscle cells, or tissue components in the wall. Thus the technique was adopted in the present studies to evaluate the effects of vasoconstrictive and vasodilative agents in the retinal functional arterioles.
It is well known that the responses to some vasoactive substances are extremely different between intracranial and extracranial cerebral arteries [15] . Therefore the contractile response of the cerebral arteries, including the internal carotid artery, to exogenous NA is significantly smaller than that obtained with 5-HT [16, 17] . Although the retinal artery is supplied blood flow from the internal carotid artery, the contractile response of the retinal functional arterioles to NA is significantly larger than that produced by 5-HT in the present study. Recently, Su et al. [3] demonstrated that NA produced a dose-dependent increase of total vascular resistance of perfused rat ocular vasculature, being larger than that produced by 5-HT. Thus the pharmacological property with a high sensitivity to NA may be one of outstanding characteristics.
Nielsen and Nyborg [6] reported that TX A 2 analog (E max ϭ94Ϯ3%, pD 2 ϭ6.88), PG E 2 (E max ϭ57Ϯ11%, pD 2 ϭ6.19), PG F 2␣ (E max ϭ67Ϯ9%, pD 2 ϭ6.20), and PG I 2 (E max ϭ65Ϯ10%, pD 2 ϭ6.51) are potent and effective agents capable of regulating isolated bovine retinal arterial smooth muscle tone. Our present study also demonstrates that arachidonic acid derivatives, such as TX A 2 , PG F 2␣ , and isocarbacyclin, caused effective vasoconstrictions and vasodilatation. The decreasing order of efficacy (E max ) in the constrictive responses was as follows: PG F 2␣ ϭU46,619Ͼ ϾNAϾ5-HT. The order in the vasodilative responses was SNPϾisocarbacyclinϾACh. These findings support the idea that PGs play an important role in the regulation of retinal circulation [6] .
On the other hand, ACh caused a dose-dependent dilatation of the pressurized retinal functional arterioles in the present experiments. The ACh-induced vasodilative response was significantly reduced by pretreatment with 3ϫ10 Ϫ5 M L-NAME. The L-NAMEmediated reduction of the ACh-induced vasodilative response was significantly reversed with an additional treatment with 10 Ϫ3 M L-arginine to 3ϫ10 Ϫ5 M L-NAME. Thus the ACh-mediated production and release of endogenous nitric oxide may contribute to the ACh-induced vasodilatation in the pressurized retinal functional arterioles. The conclusion was also confirmed by previous studies with precontracted strips of isolated bovine retinal arteries (ACh; E max ϭ47Ϯ4%, pD 2 ϭ6.19Ϯ0.05) [18] .
In fact, nitric oxide synthases have been identified in all regions of the eyes [9] . Nitric-oxide-mediated control of basal ocular blood flow is demonstrated by vasoconstriction seen in experiments where vascular endothelial cells are removed or when nitric oxide synthase is inhibited [9] . The endogenous source of nitric oxide in the eyes appears to be both endothelial and neural [19] . Furthermore, an administration of drugs that can donate nitric oxide produces vasodilation of the eye vasculature. Local vasodilatation in response to an illumination of the retina is controlled by the generation and release of nitric oxide. Nitric oxide is also implicated in several ocular pathophysiological states including uveitis, retinal ischemic disease, diabetes, and glaucoma [9] . So the retinal pressurized resistance-size arteriolar preparation will be useful for evaluating the pathophysiological roles of nitric oxide in eye diseases.
In conclusion, U46,619, NA, PG F 2␣ , and 5-HT produced dose-dependent vasoconstrictions, and SNP, ACh, isocarbacyclin, and ISP caused vasodilatation dose-dependently in the pressurized bovine retinal functional arterioles. Furthermore, ACh causes the production and release of NO, which elicits a marked vasodilation in the retinal functional arterioles without the precontraction.
